RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer
Titel:
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer
Auteur:
Baselga, José Zamagni, Claudio Gómez, Patricia Bermejo, Begoña Nagai, Shigenori E. Melichar, Bohuslav Chan, Arlene Mángel, Lászlo Bergh, Jonas Costa, Frederico Gómez, Henry L. Gradishar, William J. Hudis, Clifford A. Rapoport, Bernardo L. Roché, Henri Maeda, Patricia Huang, Liping Meinhardt, Gerold Zhang, Joshua Schwartzberg, Lee S.